Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.75 - $9.39 $1.54 Million - $3.04 Million
-323,333 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$1.51 - $6.3 $488,232 - $2.04 Million
323,333 New
323,333 $1.58 Million

Others Institutions Holding ONCT

About Oncternal Therapeutics, Inc.


  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.